European Bioanalysis Forum

Slides – EBF Autumn Focus Workshop 2022 – 1

Managing GCP in Regulated Bioanalysis – 
Considerations for Best Practices from the EBF
15-16 september 2022 – NH Malaga, Spain

PDF renditions of the powerpoint presentations given at the Focus Workshop can be viewed and downloaded from this page.
The agenda as executed can be viewed and downloaded by clicking here

Overview of EBF GCP Team discussions on GCP challenges

Day 1: 15 september 2022
9:45 10:00 Welcome and aim of the meeting
10:00 11:00 Session 1: Setting the scene
10:00 10:20 Philip Timmerman, EBF
Introduction to the meeting
10:20 10:40 Tsvetelina Ivanova, on behalf of the EBF
Overview of EBF GCP Team discussions on GCP challenges
10:40 11:00 Philip Timmerman, on behalf of the EBF
GCP for Bioanalysis – Can we learn from GLP?
11:00 11:30 Coffee break
11:30 12:30 Session 2: Looking at the different angles
11:30 11:45 Stuart McDougall, on behalf of the EBF
GCP and MHRA – setting the bar
14:45 12:00 Matthew Barfield, F. Hoffmann – La Roche
GCP from and EMA/Swiss Medic perspective
12:00 12:15 Lee Monk, UCB Biopharma
GCP from a lab QA perspective
12:15 12:30 Magnus Knutsson, Bayer (not released for publication)
GCP challenges from a Pharma/CRO project management interface perspective
12:30 13:30 Lunch Break
13:30 15:30 Session 3: Communication
During this big session we plan to go over the challenges related all aspects of study communication, incl. Issue communication / withdrawal/IC issues.
13:30 14:00 Jo Goodman/Michaela Golob, on behalf the EBF
FB from EBF GCP team discussions on communication with focus on stakeholder communication around study protocols, informed consent, sample disposition, study documentation & archiving/retention
14:00 14:20 Tessa McDonald, Intertek
Clinical Sample Handling – a CRO’s challenge
14:20 14:40 Sophia Christou, Drug Development Services Alliance Pharma
Importance of Informed Consent Process and how it relates to Regulated Bioanalysis
14:40 15:00 Adriaan Tigchelaar, Janssen R&D
Effective communication in a bioanalytical lab environment
15:00 15:30 Introduction to round tables discussion 1
Round table 1: GCP communication requirements (pre, during, post study) in practice: challenges, responsibilities and accountabilities (with focus on IC)Round table 2: What do GCP guideline/reflection papers requirements mean for BMV for the lab?Round table 3: Communication around sample disposition, study documentation & archiving/retention
15:30 16:10 Coffee Break
16:10 17:20 Round table Session 1
Delegates split into round tables on above items. Moderators rotate to tables and consolidate discussions
Survey with pre-meeting questions can be part of the round table discussions
17:20 17:30 Short logistic break
17:30 19:00 Session 5: Learnings from inspections shaping our minds
In this session we discuss experiences from inspections/risk of confusing GCP and GLP requirements
17:30 17:50 Tsvetelina Ivanova, on behalf of the EBF
FB from EBF GCP team discussions on learning from inspections
17:50 18:10 Stuart McDougall, Quotient Sciences
FB from EBF GCP team discussions on learning from inspections
18:10 19:00 “SERT” – Sharing Experience Round Table
Delegates will be invited to share experience (round table). “Cases” will be gathered from a pre-meeting survey to all registered delegates. Moderators rotate to tables and consolidate discussions.
19:00 Day 1 close out
Day 2: 16 september 2022
8:30 10:20 Session 6: Diving in deeper on Equipment maintenance and validation, role of QA and training
During this session we plan to discuss the challenges of over interpretation related to CSV, equipment validation and maintenance, incl. SOP management
8:30 8:35 Philip Timmerman, on behalf of the EBF
Introduction to day 2
8:35 9:00 Cecilia Arfvidsson, on behalf of the EBF
FB from EBF GCP team discussions on Equipment maintenance and validation – inlcudes GCP relevant info from EBF e-data and Data integrity team
9:00 9:25 Floris Bové, on behalf of the EBF
FB from EBF GCP team discussions on the role of QA
9:25 9:45 Lee Monk, UCB Biopharma
Experiences – risk based audits…
9:45 10:10 Tsvetelina Ivanova, on behalf of the EBF
FB from EBF GCP team discussions on GCP training for the BA lab
10:10 10:20 Introduction to round tables discussion day 2
Round table 4: Role of QA/risk based auditsRound table 5: Equipment maintenance/validation and CSVRound table 6: How to approach GCP training for BA?
10:20 11:00 Coffee break
11:00 12:30 Round table session 2
Delegates split into round tables on above items. Moderators rotate to tables and consolidate discussions
Survey with pre-meeting questions can be part of the round table discussions
12:30 13:30 Lunch
13:30 15:00 Session 7: Feedback from the round tables and building the EBF recommendation
During this close out afternoon session we will try to build ‘best practices’ recommendation covering several aspect discussed during the workshop round tables.
Round table 1: GCP communication requirements (pre, during, post study) in practice: challenges, responsibilities and accountabilities (with focus on IC)Round table 2: What do GCP guideline/reflection papers requirements mean for BMV for the lab?Round table 3: Communication around sample disposition, study documentation & archiving/retentionRound table 4: Role of QA/risk based audits

Round table 5: Equipment maintenance/validation and CSV

Round table 6: How to approach GCP training for BA?

Summary slides of the round tables will be added after the 15th Open Symposium
15:00 16:00 Close out & networking coffee break
Organising Committee: Tsvetelina Ivanova (Comac Medical), Joanne Goodman (AstraZeneca), Stuart McDougall (Quotient Sciences), Steve White (GlaxoSmithKline), Michael Golob (Nuvisan), Lee Monk (UCB Biopharma) and Philip Timmerman (EBF)
EBF Focus workshops are organised by the EBF vzw as non-sponsored non-profit events and are independent from EBF member companies.
Scroll to Top